$Universe Pharmaceuticals(UPC.US) plummeted -50%, a sharp reversal from the previous day's +460% surge—that spike was driven by speculative buying triggered by an acquisition announcement for a premium patent stake, a typical low-liquidity Chinese pharmaceutical small-cap stock pulse, rising fast and falling just as quickly. Volatility of this magnitude usually has little to do with the company's fundamentals and more to do with shareholding structure and liquidity issues.

$Pfizer(PFE.US) and $Johnson & Johnson(JNJ.US) edged down slightly, while $Moderna(MRNA.US) was largely flat. There's been no specific news for these three multinational pharmaceutical giants over the past two days; they've just drifted slightly lower following the overall pharmaceutical sector sentiment. The magnitude of their price movements is completely different from that of $Universe Pharmaceuticals(UPC.US).